Cornea/External Disease News

LAS VEGAS — The cyclosporine Vevye contains a newer vehicle that helps speed and improve penetration, Nicholas J. Bruns, OD, FAAO, said at Vision Expo West.

Since entering the market in 2011 as a treatment for meibomian gland dysfunction, the LipiFlow Thermal Pulsation System has consistently demonstrated its efficacy, according to a 15-year review published in Ophthalmology and Therapy.

Megatrends happen in ophthalmology when new technology addresses existing patient needs and is met with physician acceptance. There’s no better example of this than the current landscape in glaucoma.

LAS VEGAS — The pattern of fluorescein staining indicates the tear film layer affected by dry eye and, thus, dictates the treatment choice, Milton M. Hom, OD, FAAO, said at Vision Expo West.

After receiving a warning letter from the FDA on Aug. 16 citing “significant violations” related to two Regener-Eyes ophthalmic products, the company has implemented several improvements to address the concerns.

LAS VEGAS — CSI Dry Eye Software has launched new technology that uses AI to assist clinicians in making a dry eye diagnosis and developing a treatment plan, according to a company executive at Vision Expo West.

There has been a sea change in the care of patients with keratoconus in the U.S. since the FDA approval of iLink corneal collagen cross-linking in 2016.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Farhad Hafezi, MD, PhD, speaks about cross-linking applied to femto-CAIRS for the treatment of keratoconus.

Patients with type 2 diabetes and more severe peripheral neuropathy appeared to be at greater risk for developing dry eye disease, according to a study published in Optometry and Vision Science.

Prevent Blindness has declared Sept. 16 to 22 as Inflammatory Eye Disease Awareness Week and is offering free educational resources and expert videos for the public and eye care providers.